Summary.-Specific substances binding [3H]-triamcinolone acetonide have been demonstrated in the cytoplasmic fraction of the R3230AC mammary carcinoma using sucrose gradient centrifugation. These receptors, which exhibit sedimentation coefficients of 8-9 Svedberg units, are relatively specific for glucocorticoid ligands and possess a high affinity for triamcinolone acetonide (Kd a 7 x 10-8 mol/l).
THE R3230AC mammary tumour is a well differentiated adenocarcinoma of the rat which has retained many of the characteristics of the lactating mammary gland. Significant levels of certain enzymes involved in carbohydrate and lipid metabolism are present (Hilf et al., 1965) as well as detectable quantities of several gland specific substances such as lactose and casein-like proteins in the oestrogen stimulated state (Hilf, 1967) . The enzyme responsible for the synthesis of lactose, lactose synthetase, has also been found (McGuire, 1969; Turkington and Riddle, 1969 ). The R3230AC tumour, which has been classified as an oestrogen responsive neoplasm (Hilf, 1971 ), also contains specific oestrogen binding proteins (Wittliff et al., 1972a) . Although similar in many respects, on a quantitative scale the R3230AC tumour is deficient compared with the lactating mammary gland in virtually every biochemical parameter chosen.
Recently, our laboratory demonstrated the presence of a specific receptor for glucocorticoids in the cytosol of lactating mammary gland of the rat (Gardner, 1972) . These data and the previous observation by Hilf et al. (1965) that administration of hydrocortisone to the host inhibited the growth of the R3230AC tumour, prompted an examination of this neoplasm for similar glucocorticoid binding proteins. A preliminary characterization of these receptors is presented in this communication.
MATERIALS AND METHODS
Intact female rats (Fischer strain 344, wAeighing 80-90 g) were implanted with R3230AC tumour cells using a sterile trocar technique and then sacrificed by cervical dislocation at various times after transplantation. Tumours were removed during the period of exponential growth, usually at 20-25 days (Wittliff et al., 1972a) . Tumour tissue was homogenized in an appropriate volume of cold 10 mmol/l Tris HCI, pH 7 4, containing 1 a mmol/l EDTA and centrifuged at 105,000 g (0°C) for 30 minutes to prepare supernatant (cytosol) fraction.
The assay for the glucocorticoid-binding proteins closely paralleled that previously employed for the oestrogen receptors in the lactating mammary gland (Wittliff et al., 1972a) and human breast carcinoma (Wittliff et at., 1972b) , except that [3H]-triamcinolone acetonide (Schwarz/Mann, Orangeburg, N.Y., 10-6 Ci/mmol) was uised as the ligand. In each of several small shell vials, an appropriate amount of tritiunm-labelled steroid was evaporated to dryness, just before assay.
To each of these vials 50 p.1 of Tris-EDTA buffer ( ]0 mmol/l Tris HC'I 1 5 mmol/l ETDA. pH 7 4) alone, or in combination with a precalculated quantity of unlabelled steroid hormone or inhibitor, were added. A 200-400 pi volume of the 103,000 g supernatant (cytosol fraction) of tumours wNas combined with this mixture and incubated for an additional 60 min at 0°C to ensure formation of the receptor-ligand complex. A 200-400 1-l portion of the total reaction volume was layered on a linear gradient of sucrose (5-400o). These gradients were centrifuged for 15 hours (0°C) at 308,000 y using a Spinco SW-56 titaniumn rotor. Following centrifugation, the gradient tubes were punctured and a total of 40 fractions were collected into scintillation vials containing 2 ml of 990 ethanol. Ten ml of toluene scintillation cocktail (4 g OmnifluorR/l toluene) were added to eaclh fraction. The vials were then counted in a Mark II Liquid Scintillation Counter (Nuclear Chicago). Counting efficiency (38-40%o) was then calculated through external standardization of individual samples wNith a 135Ba standard. Data wtere calculated as described elstewhere (Wittliff et al., 1972a) and binding capacity was expressed as fmol (10-15 mol)/mg cytosol protein.
RESULTS AND DISCUSSION
Examination of cytosols from the R3230AC tumour revealed a single component binding the [3H]-triamcinolone acetonide, which sedimented in the 8-9 S region of a 5-4000 sucrose gradient (Fig. 1 ). Concurrent incubation with 5 mmol/l cortexolone, a steroid shown to be an inhibitor of glucocorticoid binding in a thymocytes system (Munck and Brinck-Johnsen, 1968 ) reduced ligand binding to this component significantly (Fig. 1) .
The ligand binding specificity of the glucocorticoid receptor in the tumour is presented in Table I . The relative effectiveness of the competitors, each at 5 ,umol/I concentration, showed the following relationship: triamcinolone > progesterone > hydrocortisone > cortexolone > oestradiol-17/. The order of inhibition by hydrocortisone and progesterone was reversed at the 1 ,umol/l concentration.
The glucocorticoid receptor from lactating alone or in combination with the concentration of unlabelled steroid designated. Following incubation at 0°C for 1 hour the mixtures were layered on 5-40 % sucrose gradients and centrifuged at 308,000 g for 15 hours. Total binding was determined as the radioactivity bound in the 8-9 S region of the gradient. Competition is expressed as % of total binding in the untreated (control) gradient. The competition studies using th6,5 ,umol/l concentrations of steroid were run on a 27-day old tumour; the studies using the 1 ,mol/l concentrations on a 25-day old tumour. (Scatchard, 1949) of the titration data (Fig. 2) provided a dissociation constant (Kd) = 6-6 x 10-8M), which is in the same range as that of the receptor from the lactating mammary gland (Gardner, 1972) . The number of binding sites/ mg cytosol protein was calculated as 100 fmol. This is approximately ten-fold less than measured in the cytosol of the lactating mammary gland (Gardner, 1972) .
The demonstration of a cytoplasmic 8 S receptor for triamcinolone acetonide with ligand specificities and steroid affinity similar to that of the gJucocorticoid binding protein in the lactating mammary gland serves to reinforce the parallels previously drawn between this neoplastic tissue and its normal counterpart (Hilf et al., 1965; Hilf, 1967 Hilf, , 1971 McGuire, -1969; Turkington and Riddle, 1969; Wittliff et al., 1972a) . As with most other biochemical parameters chosen for comparison, levels of the glucocorticoid binding protein are substantially less than those seen in the lactating gland.
This represents the first report of a specific glucocorticoid receptor in a rodent mammary carcinoma. Furthermore, the presence of these receptors offers a plausible mode of action for the glucocorticoid-mediated inhibition of tumour growth as well as alterations in certain enzyme activities which these hormones reportedly bring about (Hilf et al., 1965) . Thus, the glucocorticoid receptor offers yet another basis for comparison between the lactating mammary gland and the R3230AC mammary adenocarcinoma.
